5-Formyl-2'-deoxyuridine (2a), an effective inhibitor of herpes simplex virus type 1 or 2 (HSV-1, HSV-2) and vaccinia virus, was converted to the oxime (3a) and dithiolane (4a) derivatives. The oxime (3a) was equally as potent as the formyl compound against HSV-1, but one-fifth as active against HSV-2, 100 times less effective against vaccinia, and 25 times less toxic for the host cells. In addition, compound 3a was about 10 times less active than 2a in inhibiting thymidylate synthetase in vivo (as reflected by a differential inhibition of dThd and dUrd incorporation into host cell DNA). The dithiolane (4a) did not exert an appreciable effect on either virus multiplication or dThd or dUrd incorporation, nor was it cytotoxic. All these compounds as their 5'-phosphate derivatives were potent in vitro inhibitors of thymidylate synthetase (Lactobacillus casei). The inhibition was competitive with substrate with Ki/Km ratios of 0.05 for the formyl 2b, 0.5 for the oxime 3b, and 0.2 for the dithiolane 4b. Thus, 3b was 10 times less active than 2b as an in vitro inhibitor of thymidylate synthetase, which appears to corroborate the in vivo findings.

No abstract

No abstract

N‐Phenethyl‐ and N‐[2‐(3′,4′‐dimethoxyphenyl)ethyl]amides 5‐8 of cholanic acid and 3α‐acetoxy‐cholanic acid were subjected to the Bischler‐Napieralski reaction to yield the respective 3′,4′‐di‐hydroisoquinolines, 9‐12. Reaction of 5 also yielded N,N‐bis(phenethyl)cholanamidine 13. The 3′,4′‐dihydroisoquinoline 11 was converted to the tetrahydro derivative 14 and to the aromatic compounds 15 and 16.

No abstract